4-101032267-C-T
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The NM_000944.5(PPP3CA):c.1339G>A(p.Ala447Thr) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000693 in 1,443,146 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000944.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP3CA | NM_000944.5 | c.1339G>A | p.Ala447Thr | missense_variant, splice_region_variant | Exon 12 of 14 | ENST00000394854.8 | NP_000935.1 | |
PPP3CA | NM_001130691.2 | c.1339G>A | p.Ala447Thr | missense_variant, splice_region_variant | Exon 12 of 13 | NP_001124163.1 | ||
PPP3CA | NM_001130692.2 | c.1213G>A | p.Ala405Thr | missense_variant, splice_region_variant | Exon 11 of 12 | NP_001124164.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.93e-7 AC: 1AN: 1443146Hom.: 0 Cov.: 30 AF XY: 0.00000139 AC XY: 1AN XY: 717110
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy 91 Pathogenic:3
The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tools predict the variant to alter splicing and produce an abnormal transcript (SpliceAI: 0.61). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with PPP3CA related disorder (ClinVar ID: VCV000441273 / PMID: 28942967). The variant has been previously reported as de novo in a similarly affected individual (PMID: 28942967). A different missense change at the same codon (p.Ala447Ser) has been reported to be associated with PPP3CA related disorder (PMID: 32238909). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
PM6_Strong, PM1, PM5, PM2_Supporting, PP2 -
not provided Pathogenic:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 447 of the PPP3CA protein (p.Ala447Thr). This variant also falls at the last nucleotide of exon 12, which is part of the consensus splice site for this exon. This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with developmental and epileptic encephalopathy (DEE) (PMID: 28942967). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 441273). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at